Today: 2 May 2026
Micron stock pulls back from record close as Fed minutes, AI memory crunch stay in focus

Micron stock pulls back from record close as Fed minutes, AI memory crunch stay in focus

NEW YORK, December 30, 2025, 4:12 PM ET — After-hours

  • Micron shares fell about 0.6% Tuesday, a day after the memory-chip maker closed at a record.
  • The semiconductor ETF was little changed, pointing to selective profit-taking into year-end.
  • Investors stayed focused on AI-driven memory tightness and what Fed policy means for tech valuations.

Micron Technology, Inc. shares ended down 0.6% on Tuesday at $292.74, a day after the memory-chip maker finished at a record $294.37. The stock traded between $298.53 and $292.03 during the session.

The dip matters because Micron has become a key gauge for the industry’s newest bottleneck: high-bandwidth memory, a fast type of DRAM used in AI systems. The iShares Semiconductor ETF was little changed on the day.

A shifting mix of demand is driving the debate. Research firm IDC said major suppliers have redirected capacity toward AI data-center parts such as HBM and high-capacity DDR5, a newer generation of memory used in PCs and servers, leaving less conventional supply for consumer devices and pushing up prices. IDC expects 2026 DRAM and NAND supply growth of 16% and 17%, respectively, below historical norms.

Micron’s outperformance earlier in the week highlighted the trade. Investopedia reported the stock led S&P 500 gainers in Monday afternoon trading even as technology shares and the broader index were down.

The rally has been underpinned by Micron’s upbeat outlook for the February quarter and beyond, with the company flagging tight memory markets and higher 2026 capital spending plans. Micron is one of three major suppliers of HBM chips alongside Samsung Electronics and SK Hynix — components that sit next to AI processors such as Nvidia’s in data-center systems. “AI-related demand remains the biggest driver for Micron,” said Kinngai Chan, an analyst at Summit Insights. Reuters

Options positioning has also stayed constructive. Data cited by Barchart showed March 20 contracts implying a potential upside level near $342, with a put/call ratio — a measure that compares bearish puts with bullish calls — skewed toward calls.

Micron has guided investors to a sharp sequential step-up in results: revenue of $18.70 billion plus or minus $400 million and adjusted earnings per share of $8.42 plus or minus 20 cents, the company said. Its board also declared a quarterly dividend of $0.115 per share, payable Jan. 14 to shareholders of record as of Dec. 29.

The rate backdrop is also in focus for chip valuations heading into 2026. Minutes from the Federal Reserve’s December meeting released Tuesday showed officials deeply split over the last rate cut and projecting just one more cut next year; key labor and inflation data are due Jan. 9 and Jan. 13 ahead of the Fed’s Jan. 27-28 meeting.

For Micron, investors are watching whether tight supplies translate into sustained pricing power for DRAM and NAND chips, and whether the company can expand output of HBM without squeezing margins. Any update on long-term supply contracts with big cloud buyers will be a key tell.

The next company-specific date on the calendar is Micron’s annual shareholder meeting on Jan. 15, scheduled to be held virtually, a filing shows.

After Tuesday’s slide, the stock remained below the $300 mark that traders often treat as a psychological level. Year-end positioning and early-January economic data are expected to set the tone for the next move.

Stock Market Today

  • Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan
    May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could pressure margins. Forecasts project ¥1.38 trillion revenue and ¥517 billion earnings by 2028, implying modest growth. Analysts remain divided, with some optimistic on AI-driven pipeline advancements, while others caution on pricing and competitive threats. The governance changes highlight an evolving incentive model as Chugai navigates opportunities and challenges in biologics and Roche partnership dynamics.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 02.05.2026

2 May 2026
LIVEMarkets rolling coverageStarted: May 2, 2026, 12:00 AM EDTUpdated: May 2, 2026, 1:37 AM EDT Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could
US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

2 May 2026
Nasdaq 100 futures climbed 0.68% and S&P 500 futures edged up 0.06% in early after-hours trading Friday, while Dow futures slipped 0.48%. The S&P 500 and Nasdaq closed at record highs, driven by first-quarter S&P 500 profit growth of 27.8%, according to LSEG. Oil prices, inflation signals, and upcoming jobs data remain in focus. GameStop shares rose 4% after reports it was preparing an offer for eBay.
McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

2 May 2026
McDonald’s shares fell 2.37% to $286.64 on Friday, underperforming rivals ahead of its May 7 earnings report and a U.S. launch of six new McCafé specialty drinks. The company will begin selling the drinks nationwide on May 6, adding beverage specialist roles at 14,000 restaurants. Investors are watching whether the new drinks and value offers can boost traffic without slowing service or hurting margins.
Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake
Previous Story

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake

Strategy (MSTR) stock today: Shares hold near $156 after fresh bitcoin-buying update
Next Story

Strategy (MSTR) stock today: Shares hold near $156 after fresh bitcoin-buying update

Go toTop